We are live on
!
Find out more
FCM
Frontier Capital Management Portfolio holdings
AUM
$9.73B
1-Year Est. Return
55.65%
This Fund
S&P 500
This Quarter
Est. Return
+1.98%
1 Year Est. Return
+55.65%
3 Year Est. Return
+154.46%
5 Year Est. Return
+213.15%
10 Year Est. Return
+1,202.39%
AUM
$12.6B
AUM Growth
+$483M
(+4%)
Cap. Flow
+$456M
Cap. Flow
% of AUM
3.63%
Top 10 Holdings %
Top 10 Hldgs %
12.52%
Holding
374
New
23
Increased
192
Reduced
117
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aramark
ARMK
|
+$63.2M |
| 2 |
Expedia Group
EXPE
|
+$60.6M |
| 3 |
Bath & Body Works
BBWI
|
+$52.7M |
| 4 |
Moody's
MCO
|
+$44M |
| 5 |
Genpact
G
|
+$38.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pediatrix Medical
MD
|
+$71.5M |
| 2 |
WR
Westar Energy Inc
WR
|
+$46.6M |
| 3 |
GNC
GNC Holdings, Inc.
GNC
|
+$45.7M |
| 4 |
ELLI
Ellie Mae Inc
ELLI
|
+$39.1M |
| 5 |
FCS
FAIRCHILD SEMICONDUCTOR INTL INC COMMON
FCS
|
+$38.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.78% |
| 2 | Industrials | 19.59% |
| 3 | Financials | 13.29% |
| 4 | Consumer Discretionary | 11.15% |
| 5 | Healthcare | 10.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNCR
276
DELISTED
Synchronoss Technologies
SNCR
| $4.15M | 0.03% |
14,262
-2,148
| -13% | -$560K |
|
277
3D Systems Corp
DDD
$413M
| $4.04M | 0.03% |
261,466
-213,604
| -45% | -$2.2M |
|
|
AMSG
278
DELISTED
Amsurg Corp
AMSG
| $4.03M | 0.03% |
54,076
-575
| -1% | -$40.5K |
|
|
TMH
279
DELISTED
Team Health Holdings Inc
TMH
| $3.96M | 0.03% |
94,813
-1,003
| -1% | -$41K |
|
|
BLUE
280
DELISTED
bluebird bio
BLUE
| $3.94M | 0.03% |
7,156
-4,170
| -37% | -$2.56M |
|
|
EVHC
281
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $3.81M | 0.03% |
62,404
-61
| -0.1% | -$4.01K |
|
282
Darling Ingredients
DAR
$9.4B
| $3.67M | 0.03% |
+279,071
| New | +$2.81M |
|
|
INSY
283
DELISTED
Insys Therapeutics, Inc.
INSY
| $3.54M | 0.03% |
221,369
-159,065
| -42% | -$3.02M |
|
|
NEWR
284
DELISTED
New Relic, Inc.
NEWR
| $2.69M | 0.02% |
103,181
-188,457
| -65% | -$5.21M |
|
|
TACO
285
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
| $2.17M | 0.02% |
+210,201
| New | +$2.12M |
|
286
Broadcom
AVGO
$1.82T
| $2.13M | 0.02% |
137,960
-18,250
| -12% | -$247K |
|
|
MKTO
287
DELISTED
MARKETO INC COM STK (DE)
MKTO
| $2.1M | 0.02% |
107,582
-191,322
| -64% | -$3.63M |
|
|
MDCO
288
DELISTED
Medicines Co
MDCO
| $1.92M | 0.02% |
60,424
-226,135
| -79% | -$7.39M |
|
|
VRTU
289
DELISTED
Virtusa Corporation
VRTU
| $1.89M | 0.02% |
50,486
-53,898
| -52% | -$2.04M |
|
290
UnitedHealth
UNH
$386B
| $1.7M | 0.01% |
13,206
-1,747
| -12% | -$207K |
|
291
Alphabet (Google) Class C
GOOG
$4.17T
| $1.7M | 0.01% |
45,560
-6,020
| -12% | -$216K |
|
292
Cognizant
CTSH
$26.8B
| $1.63M | 0.01% |
26,061
-3,448
| -12% | -$200K |
|
293
Apple
AAPL
$5.05T
| $1.62M | 0.01% |
59,536
-7,876
| -12% | -$196K |
|
294
TJX Companies
TJX
$179B
| $1.58M | 0.01% |
40,376
-5,336
| -12% | -$194K |
|
|
AGN
295
DELISTED
Allergan plc
AGN
| $1.26M | 0.01% |
4,707
-623
| -12% | -$178K |
|
296
Blackrock
BLK
$171B
| $1.23M | 0.01% |
3,596
-476
| -12% | -$151K |
|
297
Bristol-Myers Squibb
BMY
$130B
| $1.22M | 0.01% |
19,071
-2,523
| -12% | -$159K |
|
298
Oracle
ORCL
$348B
| $1.02M | 0.01% |
24,973
-3,304
| -12% | -$122K |
|
299
American International
AIG
$42.7B
| $1M | 0.01% |
18,554
-2,455
| -12% | -$133K |
|
300
Biogen
BIIB
$30.6B
| $983K | 0.01% |
3,777
-500
| -12% | -$132K |
|
Similar funds
HL
DCP
CCM
URS
CIM
MPI
TIM
DPIM
Frontier Capital Management's Q1 2016 Portfolio in Review
As of Q1 2016, Frontier Capital Management held 374 positions worth $12.6B, up 4% from $12.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Frontier Capital Management deployed $456M of net new capital in Q1 2016, opening 23 new positions and adding to 192 existing holdings. Its largest new stake was Expedia Group: 568,316 shares worth $61.3M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Pediatrix Medical, an estimated $71.5M trimmed.
- Frontier Capital Management's largest Q1 2016 buy was Expedia Group: 568,316 shares worth $61.3M.
- Frontier Capital Management added most to Aramark in Q1 2016, an estimated $63.2M increase.
- Frontier Capital Management's biggest Q1 2016 reduction was Pediatrix Medical, cutting an estimated $71.5M.
- Frontier Capital Management fully exited Cabot Corp in Q1 2016, selling an estimated $30.8M.
- Frontier Capital Management's ten largest holdings make up 13% of its $12.6B portfolio in Q1 2016.
- Frontier Capital Management opened 23 new positions and closed 32 in Q1 2016.
- Frontier Capital Management's portfolio value rose 4% quarter-over-quarter to $12.6B.
Based on Frontier Capital Management's 13F filing for Q1 2016, filed 4 May 2016.